C07D 213/14
Preparation from compounds containing heterocyclic oxygen
C07D213/14 (Preparation from compounds containing heterocyclic oxygen) appears on 28 US grants and 26 published applications in this corpus.
Search patents in C07D- Granted patents
- 28
- Published applications
- 26
- Assignees
- 19
- Inventors
- 90
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 4 | 4 |
| 2014 | 3 | 2 |
| 2015 | 3 | 3 |
| 2016 | 1 | 1 |
| 2017 | 1 | 3 |
| 2018 | 3 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Combination pharmaceutical agents as RSV inhibitors8 Apr 2025US 12,268,694 B2Enanta Pharmaceuticals, Inc.
- Oxazolidinones as TarO inhibitors29 Aug 2023US 11,738,010 B2Merck Sharp & Dohme Corp.
- Oxazolidinones as taro inhibitors12 Oct 2021US 11,141,410 B2Merck Sharp & Dohme Corp.
- Combination pharmaceutical agents as RSV inhibitors5 Jan 2021US 10,881,666 B2Enanta Pharmaceuticals, Inc.
- Piperidine or piperazine linked imidazole and triazole derivatives and methods of use18 Aug 2020US 10,745,377 B2Merck Sharp & Dohme Corp.
- Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereof25 Jan 2024US 2024/0025858 A1
- Inhibitors of the bromodomain phd finger transcription factor (bptf) as anti-cancer agents7 Dec 2023US 2023/0391730 A1Regents of the University of Minnesota
- Combination pharmaceutical agents as rsv inhibitors13 Oct 2022US 2022/0323460 A1Enanta Pharmaceuticals, Inc.
- Oxazolidinones as taro inhibitors11 Nov 2021US 2021/0346364 A1Merck Sharp & Dohme Corp.
- Oxazolidinones as taro inhibitors20 Aug 2020US 2020/0261436 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Pyridine/picoline production process4US 5,969,143 AMobil Oil Corporation · 1999
- Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders4US 8,299,307 B2Acucela Inc. · 2012
- Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders4US 8,389,771 B2Acucela Inc. · 2013
- Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders4US 8,492,589 B2Acucela Inc. · 2013
- Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders3US 8,766,007 B2Acucela Inc. · 2014